A business in context

RCKT research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 8-K · Current report

    Report date 2026-09-30 · 0001140361-26-038818 · Items 1.01,2.03,3.02,7.01,9.01

  2. 4 · Ownership change

    Report date 2026-09-11 · 0001140361-26-036688

  3. 8-K · Current report

    Report date 2026-09-15 · 0001140361-26-036563 · Items 7.01,9.01

  4. 8-K · Current report

    Report date 2026-08-21 · 0001140361-26-034689 · Items 5.02

  5. 4 · Ownership change

    Report date 2026-08-18 · 0001140361-26-033915

  6. 4 · Ownership change

    Report date 2026-08-18 · 0001140361-26-033913

  7. 4 · Ownership change

    Report date 2026-08-13 · 0001140361-26-033417

  8. 4 · Ownership change

    Report date 2026-08-13 · 0001140361-26-033413

  9. 4 · Ownership change

    Report date 2026-08-11 · 0001140361-26-032818

  10. 4 · Ownership change

    Report date 2026-08-11 · 0001140361-26-032816

  11. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-342348

  12. 8-K · Current report

    Report date 2026-08-10 · 0001140361-26-032028 · Items 2.02,9.01

  13. 4 · Ownership change

    Report date 2026-08-03 · 0001140361-26-031473

  14. 8-K · Current report

    Report date 2026-08-03 · 0001140361-26-030568 · Items 7.01,9.01

  15. 8-K · Current report

    Report date 2026-06-24 · 0001140361-26-026982 · Items 5.02

  16. 8-K · Current report

    Report date 2026-06-10 · 0001140361-26-024997 · Items 2.01,7.01,9.01

  17. 8-K · Current report

    Report date 2026-05-20 · 0001140361-26-022311 · Items 5.07

  18. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-211873

  19. 8-K · Current report

    Report date 2026-05-07 · 0001140361-26-019573 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2026-04-26 · 0001140361-26-017275 · Items 1.01,7.01,9.01

  21. DEF 14A · Proxy statement

    Report date 2026-05-20 · 0001140361-26-013335

  22. 8-K · Current report

    Report date 2026-03-26 · 0001140361-26-011573 · Items 7.01,9.01

  23. 8-K · Current report

    Report date 2026-03-10 · 0001140361-26-008853 · Items 1.01,1.02,9.01

  24. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076551

  25. 8-K · Current report

    Report date 2026-02-26 · 0001140361-26-006981 · Items 2.02,9.01

  26. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-269474

  27. 8-K · Current report

    Report date 2025-11-06 · 0001140361-25-040774 · Items 2.02,9.01

  28. 8-K · Current report

    Report date 2025-10-14 · 0001140361-25-038030 · Items 8.01,9.01

  29. 8-K · Current report

    Report date 2025-09-29 · 0001140361-25-037237 · Items 5.02

  30. 8-K · Current report

    Report date 2025-10-03 · 0001140361-25-037163 · Items 8.01

  31. 8-K · Current report

    Report date 2025-09-23 · 0001140361-25-036556 · Items 5.02

  32. 8-K · Current report

    Report date 2025-09-11 · 0001140361-25-035251 · Items 1.01,9.01

  33. 8-K · Current report

    Report date 2025-08-20 · 0001140361-25-032502 · Items 5.02

  34. 8-K · Current report

    Report date 2025-08-20 · 0001140361-25-032012 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2025-08-04 · 0001140361-25-029582 · Items 2.02,5.02,9.01

  36. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-104996

  37. 8-K · Current report

    Report date 2025-07-24 · 0001140361-25-027032 · Items 8.01,9.01

  38. 8-K · Current report

    Report date 2025-07-23 · 0001140361-25-026946 · Items 2.05

  39. 8-K · Current report

    Report date 2025-07-17 · 0001140361-25-026132 · Items 8.01,9.01

  40. 8-K · Current report

    Report date 2025-07-07 · 0001140361-25-025673 · Items 5.02

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 7 transaction rows7SGrant / award: 14 transaction rows14AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

22 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-11
2026-09-15
Wilson MartinS · Sale
Disposed
Common Stock75364.03.4
2026-08-18
2026-08-20
Wilson MartinS · Sale
Disposed
Common Stock631.03.38
2026-08-18
2026-08-20
Shah GauravS · Sale
Disposed
Common Stock2293.03.38
2026-08-13
2026-08-17
Shah GauravS · Sale
Disposed
Common Stock2837.03.38
2026-08-13
2026-08-17
Wilson MartinS · Sale
Disposed
Common Stock3493.03.38
2026-08-11
2026-08-13
Stevens Christopher JamesS · Sale
Disposed
Common Stock36658.03.5
2026-08-11
2026-08-13
Chaudhuri SarbaniS · Sale
Disposed
Common Stock4701.03.5
2026-08-03
2026-08-05
Stevens Christopher JamesA · Grant / award
Acquired
Common Stock73313.00.0
2026-08-03
2026-08-05
Stevens Christopher JamesA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
101428.00.0
2026-08-03
2026-08-05
SOUTHWELL DAVID PJ · Other (see filing)
Acquired
Common Stock150000.00.0
2026-06-18
2026-07-06
WONG RODERICKA · Grant / award
Acquired
Common Stock27832.00.0
2026-06-18
2026-07-06
WONG RODERICKA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
78960.00.0
2026-06-18
2026-07-06
Fong PeterA · Grant / award
Acquired
Common Stock22862.00.0
2026-06-18
2026-07-06
Fong PeterA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
64860.00.0
2026-06-18
2026-07-06
Dolsten MikaelA · Grant / award
Acquired
Common Stock22862.00.0
2026-06-18
2026-07-06
Dolsten MikaelA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
64860.00.0
2026-06-18
2026-07-06
Malik Fady IbrahamA · Grant / award
Acquired
Common Stock22862.00.0
2026-06-18
2026-07-06
Malik Fady IbrahamA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
64860.00.0
2026-06-18
2026-07-06
SOUTHWELL DAVID PA · Grant / award
Acquired
Common Stock22862.00.0
2026-06-18
2026-07-06
SOUTHWELL DAVID PA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
64860.00.0
2026-06-18
2026-07-06
BOESS CARSTENA · Grant / award
Acquired
Common Stock22862.00.0
2026-06-18
2026-07-06
BOESS CARSTENA · Grant / award
Acquired
Stock Option (Right to Buy)
Derivative security
64860.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001281895ROCKET PHARMACEUTICALS, INC.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • INOTEK PHARMACEUTICALS CORP · former SEC name · 2004-02-25 to 2017-12-22

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$0$0
2022-12-31$0$0
2021-12-31$0$0
2020-12-31$0$0
2019-12-31$0$0
2018-12-31$0$0
2017-12-31$0$0

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗